海外の治験の状況「濾胞性リンパ腫」での検索結果
413件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- TGR1202 in Relapsed and Refractory Follicular Lymphoma
- Follicular Lymphoma;Follicular Lymphoma;Follicular Lymphoma
- United States
- 2017-06-01
Recruiting
- Dietary Intervention in Follicular Lymphoma
- Follicular Lymphoma
- Norway
- 2007-04-02
Recruiting
- Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma
- Stage I Grade 1 Follicular Lymphoma;Stage I Grade 2 Follicular Lymphoma;Stage II Grade 1 Contiguous Follicular Lymphoma;Stage II Grade 1 Non-Contiguous Follicular Lymphoma;Stage II Grade 2 Contiguous Follicular Lymphoma;Stage II Grade 2 Non-Contiguous Follicular Lymphoma;Stage III Grade 1 Follicular Lymphoma;Stage III Grade 2 Follicular Lymphoma;Stage IV Grade 1 Follicular Lymphoma;Stage IV Grade 2 Follicular Lymphoma
- United States
- 2014-12-15
Recruiting
- Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT)
- Follicular Lymphoma
- France
- 2014-11-25
Recruiting
- A study comparing PF-05280586 to MabThera® (rituximab) in patients with follicular lymphoma who have not received previous treatment.
- CD20-positive, low tumor burden, Follicular Lymphoma
- Austria, Belarus, Belgium, Brazil, Canada, Croatia, Egypt, France, Germany, Greece, India, Italy, Japan, Lebanon, Mexico, Other, Peru, Philippines, Poland, Portugal, Republic of Korea, Romania, Russian Federation, South Africa, Spain, Switzerland, Thailand, Turkey, Ukraine, United Kingdom, United States of America
- 2015-05-26
Recruiting
- Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma
- Follicular Lymphoma
- China
- 2015-05-07
Recruiting
- Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma
- Recurrent Follicular Lymphoma
- China
- 2015-04-27
Recruiting
- Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
- Refractory Follicular Lymphoma;Relapsed Follicular Lymphoma
- United States
- 2016-11-02
Recruiting
- TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma
- Grade 1 Follicular Lymphoma;Grade 2 Follicular Lymphoma;Grade 3a Follicular Lymphoma;Recurrent Follicular Lymphoma;Refractory Follicular Lymphoma;Mantle Cell Lymphoma;Marginal Zone Lymphoma
- United States
- 2016-10-06
Recruiting
- An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
- Lymphoma
- Australia, Canada, Czechia, Denmark, Germany, Hungary, Israel, Italy, Poland, Spain, Sweden, United Kingdom, United States
- 2017-04-20